The influence of antitumor vaccines of iepor series on TNF, IL-1 and IL-2 production in lewis lung carcinoma bearing mice

Experimental Oncology

Volumn 24, Issue 4, 2002, Pages 295-300

  Savtsova, Z D ^a   Yudina, O Yu ^a   Fedosova, N I ^a   Usach, O M ^a   Tanasienko, O A ^a   Lisovenko, G S ^a   Novichenko, L N ^a   Potebnya, G P ^a  

^a R E KAVETSKY INSTITUTE OF EXPERIMENTAL PATHOLOGY   (Ukraine)

Author keywords

Antitumor vaccine; Bacillus subtilis AB 56; Blood serum; IL 1; IL 2; Lewis lung carcinoma; Macrophage; Natural killer cells; TNF

Indexed keywords

BACILLUS SUBTILIS AB 56 FILTRATE; CANCER ANTIBODY; CANCER VACCINE; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 2; INTERLEUKIN 6; LECTIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACILLUS SUBTILIS; CANCER INHIBITION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOTOXICITY; FEMALE; IMMUNIZATION; LUNG CARCINOMA; METASTASIS INHIBITION; MOLECULAR DYNAMICS; MOUSE; NATURAL KILLER CELL; NONHUMAN; SCORING SYSTEM; SPLEEN CELL; TUMOR CELL CULTURE; VACCINATION;

EID: 0036966771     PISSN: 02043564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Nawroccki S, Mackiewicz A. Genetically modified tumor vaccines - where we are today. Cancer Treat Rev 1999; 25: 29-46.
2. 6 A61K 39/00, C07K 14/47. Anti-cancer vaccine. Bystryn JC. - No 08/865114; NPK 424/2771.1.
3. 6 A61K 329/395, C12P 21/08. Vaccines for treatment of lymphoma and leukemia. Denney DW. - Genitope Corp. - No 08/761277; NPK 424/131.1.
4. Potebnya GP, Zagadarchuk NL, Savtsova ZD, Litvinenko AA. Antitumor activity of vaccines prepared with the use of filtrate of culture medium of Bac. mesenrefocus AB-56 or AB-56 antibiotic. Clin Surgery 1998; (1): 37-8 (In Ukrainian).
5. Kolesnik EA, Potebnya GP, Kikot VA, Chorny VA, Lisovenko GS, Semernikov VA. Antitumor autovaccine in the colorectal cancer patient's treatment. Oncology 1999; (2): 104-8 (In Russian).
6. Potebnya GP, Smolanka II, Lisovenko GS, Romashko NI, Semernikov VA, Kolesnik EA. Efficacy of immunotherapy with autovaccine in the treatment of lung cancer patients. Oncology 2000; 2-3: 191-4 (In Russian).
7. Tanasienko OA, Potebnya GP, Sydorenko MV, Shlyakhovenko VO. Influence of the antitumor antibiotic from B. mesentericus AB-56 on the immunogenicity of tumor cells. Dop NAS Ukraine 1999; (6): 192-5 (In Ukrainian).
8. Potebnya GP, Tanasienko OA, Shlyakhovenko VA. Influence of antitumor vaccine on the metastasis of Lewis carcinoma at various schemes of inoculation. Dop NAS Ukraine 1999; (9): 180-5 (In Russian).
9. Savtsova ZD, Usach OM, Voyejkova IM, Yudina OY, Leonov YuI, Novichenko NL, Shlyakhovenko VO, Potebnya GP. Features of influence of antineoplastic vaccines (series IEPOR) prepared on different technologies, on effector reactions of specific and nonspecific immunity. Proc Ser Biol Ecol (National University Kyiv Mohyla Academy) 2001; 19: 26-31 (In Ukrainian).
10. Yarilin AA. Antigen presentation and initiation of immune response. Uspehi Physiol Nauk 2000; 31: 38-47 (In Russian).
11. Ketlinsky SA, Kalinina NM. Cytokines of mononuclear phagocytes in regulation of inflammation and immunity. Immunologiya 1995; (3): 30-44 (In Russian).
12. Berezhnaya NM, Chekhun VF. Interleukins and cancer. Kyev: DIA, 2000. 224 p (In Russian).
13. Potebnya GP, Tanasienko OA, Cheremshenko NL, Shlyakhovenko VA, Kovalenko EA, Getman EI. Regularities of biosynthesis of cytotoxic lectines by Bacillus subtilis B-7025 culture, growing on different media. Ukr J Chemother 2002; (1): 54-7 (In Russian).
14. Potebnya GP, Tanasienko OA, Lisovenko GS, Kohanovskaja LN, Litvinenko AA, Cheremshenko NL. Influence of cultural conditions on synthesis of cytotoxic substances by Bacillus subtilis B-7025. Ukr J Chemother 2001; (4): 38-41 (In Russian).
15. Patent 1667, MPK A61 K35/12. The way of antitumor vaccine production. Zatula DG, Sitenko VK, Lisovenko GS, Tanasienko OA, Zavalniuk VA, Zagadarchuk NL, Khomyak OG, Syadro TA. - IEPOR NAS UA. - No 3478519/28-14; Bul (3): 42 (In Ukrainian).
16. Patent 19910, MIIK C12 P21/00. The way to receive the substance with antitumor activity. Zatula DG, Tanasienko OA, Khomyak OG, Sitenko VK, Zagadarchuk NL, Syadro TA, Zavalniuk VA, Lisovenko GS. - IEPOR NAS UA. - No 3507803/28-14; Bul (6) (In Ukrainian).
17. Zagadarchuk NL. The experimental substantion of methods to enhance the efficiency of the antitumor vaccine produced with an employment of B. mesentericus AB-56 metabolic products: Ph.D. Thesis. Kyiv, 1997. 143 p (In Ukrainian).
18. Cherdyntseva NV, Kokorev OV, Konovalova NP, Kagiya VT. Radiosensitizer AK-2123 enhances cytotoxic and cytostatic activity of splenocytes and macrophages in Lewis lung carcinoma bearing mice treated with cyclophosphamide. Exp Oncol 1997; 19: 333-7 (In Russian).
19. Hokland M, Heron I, Berg K, Hokland P. Natural killer cell activity correlates with the amount of beta 2-microglobulin on human peripheral blood lymphocytes. Cell Immunol 1982; 72: 40-51.
20. Pietrangelli CE, Scamene E, Edelsen P. Measurement of 5′-nucleotidase in mouse peritoneal macrophages in listeriosis. Immunity 1988; 32: 1206-10.
21. Medvedev AE, Fucks BB, Bovin NV, Zemlyakov AE. Study of immunomodulating activity of new derivatives of MDP in vitro. Bull Exp Biol Med 1992; (12):626-8 (In Russian).
22. Fisch H, Gifford G. In vitro production of rabbit macrophage tumor cell cytotoxin. Int J Cancer 1983; 32: 105-12.
23. Lymphocytes. A practical approach. Klaus GGB, ed. Moscow: Mir, 1990. 395 p (In Russian).
24. Lakin GF. Biometrics. Moscow: Vysshaya shkola, 1980. 290 p (In Russian).
25. Holden RJ, Pakula IS, Mooney PA. An immunological model connecting the pathogenesis of stress, depression and carcinoma. Med Hypotheses 1998; 51: 309-14.
26. Mysliwska J, Bryl E, Zorena K, Balon J, Foerster J, Mysliwski A. Overactivity of tumor necrosis factor-alpha but not interleukin-6 in associated with low natural killer cytotoxic activity in the elderly. Gerontology 1997; 43: 158-67.
27. Kovalchuk LV, Gancovskaya LV, Sokolova Ye V, Titovets RYe. Cytokine regulation of antitumor macrophage activity: experimental basis for adoptive macrophage therapy of cancer. Immunology 1995; (3): 52-4 (In Russian).
28. Okulov VB. Influence of macrophages on tissue regeneration and reparation. Oncological aspects. In: Immunotherapy of cancer. Moskow: 1999: 1-13 p (In Russian).
29. Wallace P, Morahan P. Role of macrophages in the immunotherapy of Lewis lung peritoneal carcinomatosis. J Leuk Biol 1994; (1): 41-51.
30. Hori K, Nihchich F, Ehrke J. Role of tumor necrosis factors and interleukin 1 in γ-interferon-promoted activation of mouse tumoricidal macrophages. Cancer Res 1989; 49: 2606-14.
31. Usach OM, Tanasienko OA, Yudina OYu, Potebnya GP, Savtsova ZD. Efficiency and characteristics of antitumor vaccines based on metabolites of Bacillus subtilis 7025 cultured on different media. Exp Oncol 2002; 24: 76-9 (In Russian).